Received 5 October 2012
aDepartment of Physics, Faculty of Sciences, Erciyes University, 38039 Kayseri, Turkey,bPharmaceutical Chemistry Department, Faculty of Pharmacy, Al Azhar University, Egypt,cMamedaliev Institute of Petrochemical Processes, National Academy of Sciences of Azerbaijan, Baku, Azerbaijan, and dDepartment of Organic Chemistry, Baku State University, Baku, Azerbaijan
Correspondence e-mail: firstname.lastname@example.org
The asymmetric unit of the title compound, C25H22N2O, contains two independent molecules (A and B), with significantly different conformations. In molecule A, the central imidazole ring makes dihedral angles of 88.26 (10) and 12.74 (11)° with the two phenyl rings, and 22.06 (9)° with the benzene ring. In molecule B, one of the phenyl rings is disordered over two sites, each having an occupancy of 0.5. Here the central imidazole ring forms dihedral angles of 79.24 (10)° with the ordered phenyl ring, and 3.5 (5) and 22.6 (5)° with the two parts of the disordered phenyl ring. The dihedral angle involving the benzene ring is 67.49 (10)°. The -N-C(H2)-C(H)-C(H2) torsion angles of the prop-1-ene group in the two molecules are very similar, 0.5 (3) and 1.3 (4)° for molecules A and B, respectively. The crystal structure is stabilized by C-H interactions.
For the synthesis, see: Mohamed et al. (2012). For biological properties of imidazoles, see: Puratchikody & Doble (2007); Bhatnagar et al. (2011); Antolini et al. (1999); Wang et al. (2002). For standard bond-length data, see: Allen et al. (1987).
Data collection: APEX2 (Bruker, 2005); cell refinement: SAINT-Plus (Bruker, 2001); data reduction: SAINT-Plus; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012); software used to prepare material for publication: WinGX (Farrugia, 2012) and PLATON (Spek, 2009).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: SU2509 ).
The National Academy of Sciences of Azerbaijan, Erciyes University and Baku state University are gratefully acknowledged for supporting this study.
Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
Antolini, M., Bozzoli, A. & Ghiron, C. (1999). Bioorg. Med. Chem. Lett. 9, 1023-1028.
Bhatnagar, A., Sharma, P. K. & Kumar, N. (2011). Int. J. Pharm. Tech. Res. 3, 268-282.
Bruker (2001). SAINT-Plus. Bruker AXS, Madison, Wisconsin, USA.
Bruker (2005). APEX2. Bruker AXS, Madison, Wisconsin, USA.
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.
Mohamed, S. K., Akkurt, M., Fronczek, F. R., Marzouk, A. A. E. & Abdelhamid, A. A. (2012). Acta Cryst. E68, o2979-o2980.
Puratchikody, A. & Doble, M. (2007). Bioorg. Med. Chem. Lett. 15, 1083-1090.
Sheldrick, G. M. (2003). SADABS. University of Göttingen, Germany.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
Wang, L., Woods, K. W. & Li, Q. (2002). J. Med. Chem. 45, 1697-1711.